Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeApollo NeuroscienceBeat Stress Through New Wearable Device

Beat Stress Through New Wearable Device

Today Apollo Neuroscience introduced the first wearable that actively helps your body beat stress, for better sleep, energy, and more. While other wearables track your body, Apollo is the first ever to empower you to change it by delivering gentle waves of vibration clinically shown to rapidly restore your body’s natural equilibrium.

Developed by physicians and neuroscientists at the University of Pittsburgh, Apollo’s gentle waves of vibration signal safety to the body through your sense of touch and rapidly improve heart rate variability (HRV), a key metric of health and recovery. These safety signals help engage the parasympathetic nervous system, resulting in improved heart rate variability (HRV), sleep, focus, calm, energy, and more. Apollo works fast, at the moment that you need it, offering you control over your stress, so you can tackle whatever comes next.

“Chronic daily stress can have a profound, disruptive effect on our bodies and result in harmful symptoms including insomnia, anxiety disorders, chronic pain, cognitive dysfunction, and cardiovascular disease,” said Dr. David Rabin, co-inventor of the Apollo technology and chief innovation officer and co-founder at Apollo Neuroscience. “Apollo is the only technology that actually improves HRV and accelerates your body’s recovery from stress so you can feel energized, focused, and sleep better.”

Apollo works in tandem with an intuitive app for iOS and Android. Users can choose from a variety of Apollo programs to target and achieve goals in specific areas including:

  • Energy – It gives you a boost of energy when you’re feeling tired and sluggish.
  • Focus – Filters out distraction and settles your nerves for clear, calm focus.
  • Mindfulness – Prepares you for meditation by facilitating connection between mind and body.
  • Relaxation – Rapidly relieves stress for deep relaxation.
  • Sleep – Quiets your mind and eases you into restful sleep.
  • Social – Elevates mood and energy for social situations, whether at work or play.
  • Recover – Accelerates your body’s recovery after a workout.

Apollo has been evaluated clinically in university-led trials, has undergone successful pilots to prevent burnout in the workplace, and has had over 2000 early users, with consistent results across the board. Over 90 percent of users reported enhanced productivity, focus and sleep when using Apollo.

“Many devices track your HRV and monitor your sleep, but do nothing to improve them. That’s where Apollo comes in,” said Kathryn Fantauzzi, chief executive officer and co-founder, Apollo Neuroscience. “We’re delivering the first wearable experience that actively improves your body’s resilience to stress, so you can have more energy, feel more relaxed, and get more sleep. Apollo’s mission is to democratize neuroscience discoveries to empower people to take control of their health.”

Apollo is made in the USA and comes with a one-year warranty. It features a versatile design that can be worn on the wrist or ankle and is available in 2 colors: stealth and silver. Apollo is waterproof, Bluetooth-enabled, and offers a powerful battery with up to three days in between charges.

Apollo is now available for preorder for an all-inclusive price of $199 (a $360 value). Customers receive the Apollo wearable along with access to the free app with seven goal-based programs, new features and program upgrades, exclusive content, and advanced access to new accessories and exclusive discounts. Shipping of the Apollo wearable will commence in January 2020.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy